Related Experiment Video

Updated: Aug 4, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Frequency of lipid-lowering drug therapy after coronary and carotid operations for atherosclerosis

C S Roberts1, K D Donovan, P J McCarthy

  • 1Department of Surgery, University of North Carolina School of Medicine, Chapel Hill, USA.

Southern Medical Journal
|May 8, 2000
PubMed

Insights

Secondary prevention with lipid-lowering drugs is underemphasized after coronary artery bypass grafting (CABG) and carotid endarterectomy (CE). Postoperative lipid-lowering therapy rates were low, highlighting a need for improved risk reduction programs.

Area of Science:

  • Cardiovascular Surgery
  • Preventive Cardiology
  • Atherosclerosis Management

Background:

  • Coronary artery bypass grafting (CABG) and carotid endarterectomy (CE) are surgical interventions for severe atherosclerosis.
  • Secondary preventive measures following these procedures are often overlooked.
  • Atherosclerosis affects both coronary and carotid arteries, necessitating comprehensive risk management.

Purpose of the Study:

  • To evaluate the utilization of lipid-lowering drug therapy before and after CABG and CE.
  • To identify potential gaps in secondary prevention strategies for patients undergoing these vascular surgeries.
  • To inform the development of targeted postoperative risk reduction programs.

Main Methods:

  • Retrospective observational study design.
  • Analysis of patient data from 1997, focusing on lipid-lowering drug prescriptions.
  • Comparison of pre- and post-operative medication use in patients undergoing CABG and CE.

Main Results:

  • Only 27% of CABG patients received lipid-lowering drugs preoperatively, increasing to 37% postoperatively.
  • Preoperative lipid-lowering drug use was lower in CE patients (20%), with a further decrease to 14% upon discharge.
  • A significant proportion (39%) of CE patients also had co-existing coronary artery disease, underscoring the need for comprehensive care.

Conclusions:

  • Secondary prevention strategies, particularly lipid-lowering therapy, are underemphasized post-CABG and CE.
  • The low rates of prescribed lipid-lowering drugs indicate a critical need for enhanced postoperative risk reduction programs.
  • Implementing structured programs can improve long-term outcomes for patients with widespread atherosclerosis.
Abstract

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...